RedHill Biopharma Ltd. (RDHL)

7.32
0.04 0.55
NASDAQ : Health Technology
Prev Close 7.28
Open 7.30
Day Low/High 7.21 / 7.37
52 Wk Low/High 3.26 / 11.35
Volume 103.59K
Avg Volume 448.40K
Exchange NASDAQ
Shares Outstanding 35.27M
Market Cap 247.59M
EPS -1.40
P/E Ratio 69.45
Div & Yield N.A. (N.A)

Latest News

Let's Head Overseas for a Trio of Undervalued Healthcare Plays

Let's Head Overseas for a Trio of Undervalued Healthcare Plays

These promising companies look like good names for patient buy-and-hold investors.

2 Picks, 2 Pans Among Small-Cap Biotechs Laboring in the Covid-19 Fields

2 Picks, 2 Pans Among Small-Cap Biotechs Laboring in the Covid-19 Fields

Quotient Limited and Redhill Biopharma could deliver for shareholders, while Novavax Inc. and Inovio Pharmaceuticals may not in the end.

3 Small-Caps That Look Like Bargains at Current Trading Levels

3 Small-Caps That Look Like Bargains at Current Trading Levels

The trio consists of BioDelivery Sciences International, Beazer Homes USA and Redhill Biopharma.

2 Key 'Rules' When Investing in Biotech Stocks

2 Key 'Rules' When Investing in Biotech Stocks

Remembering these 'rules of the road' is vital in this highly volatile space.

How I Invest In Biotech Stocks

How I Invest In Biotech Stocks

Here's two 'rules of the road' when investing in this highly volatile space.

Celgene Down After Pulling Plug on Crohn's Disease Drug Study -- Biotech Movers

Celgene Down After Pulling Plug on Crohn's Disease Drug Study -- Biotech Movers

The Summit, N.J.-based firm said Thursday that it was discontinuing the GED-0301 (mongersen) Phase 3 Revolve study in Crohn's disease and the extension trial.

3 Small Biotechs That Still Have Upside

3 Small Biotechs That Still Have Upside

Companies developing drugs for cancer, eye problems and pets -- offer untapped value.

One Small Pharma Stock Has Big Potential

One Small Pharma Stock Has Big Potential

Redhill has some promising drugs in its pipeline, and is well funded.

5 Small-Cap Biotechs With Big Potential

5 Small-Cap Biotechs With Big Potential

These 5 stocks all have positive catalysts on the horizon.

5 Small-Cap Biotechs With Big Potential

5 Small-Cap Biotechs With Big Potential

These 5 stocks all have positive catalysts on the horizon.